Coverage dated October 23, 2026 to October 24, 2026

Ebola vaccine trial begins in DR Congo

Headline from MedicalXpress

The first clinical trial of an Ebola vaccine in the outbreak gripping the Democratic Republic of Congo began Friday, the head of the World Health Organization said.

MedicalXpress's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Earlier updates in this story

Read the reports

Reports & sources

4 articles, oldest first.

Bloomberg
Ebola Vaccine Trial Begins in Congo With Three Shots in Sight (opens Bloomberg)
Published Oct 23, 2026
Bloomberg's feed description
A pivotal trial of vaccines against the strain of Ebola that’s driving a deadly outbreak across parts of Africa has begun in the Democratic Republic of Congo where the epidemic originated and the vast majority of cases and deaths have occurred.
Forbes
Ebola Vaccine Trials Begin In DRC As Death Toll Nears 4,700 (opens Forbes)
Published Oct 23, 2026
Forbes's feed description
Late-stage trials for a vaccine targeting the deadly Bundibugyo Ebola strain have launched in the DCR as the country continues to struggle under its most deadly Ebola outbreak ever.
Al Jazeera
WHO announces start of Ebola vaccine clinical trial in DR Congo (opens Al Jazeera)
Published Oct 23, 2026
Al Jazeera's feed description
A clinical trial begins to test the safety, efficacy and immunogenicity of multiple vaccines.
MedicalXpress
Ebola vaccine trial begins in DR Congo (opens MedicalXpress)
Published Oct 24, 2026
MedicalXpress's feed description
The first clinical trial of an Ebola vaccine in the outbreak gripping the Democratic Republic of Congo began Friday, the head of the World Health Organization said.